MYCRONIC AB (1MYCR.MI) Fundamental Analysis & Valuation

BIT:1MYCRSE0025158629

Current stock price

25.16 EUR
+5.79 (+29.86%)
Last:

This 1MYCR.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. 1MYCR.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1MYCR was profitable.
  • In the past year 1MYCR had a positive cash flow from operations.
  • In the past 5 years 1MYCR has always been profitable.
  • Each year in the past 5 years 1MYCR had a positive operating cash flow.
1MYCR.MI Yearly Net Income VS EBIT VS OCF VS FCF1MYCR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • 1MYCR has a Return On Assets of 14.29%. This is amongst the best in the industry. 1MYCR outperforms 96.30% of its industry peers.
  • Looking at the Return On Equity, with a value of 21.94%, 1MYCR belongs to the top of the industry, outperforming 90.74% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 19.52%, 1MYCR belongs to the best of the industry, outperforming 94.44% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1MYCR is significantly above the industry average of 7.73%.
Industry RankSector Rank
ROA 14.29%
ROE 21.94%
ROIC 19.52%
ROA(3y)14.14%
ROA(5y)13.2%
ROE(3y)22.24%
ROE(5y)20.71%
ROIC(3y)20.09%
ROIC(5y)18.35%
1MYCR.MI Yearly ROA, ROE, ROIC1MYCR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • With an excellent Profit Margin value of 19.65%, 1MYCR belongs to the best of the industry, outperforming 98.15% of the companies in the same industry.
  • 1MYCR's Profit Margin has improved in the last couple of years.
  • The Operating Margin of 1MYCR (24.93%) is better than 98.15% of its industry peers.
  • In the last couple of years the Operating Margin of 1MYCR has remained more or less at the same level.
  • 1MYCR has a better Gross Margin (52.94%) than 68.52% of its industry peers.
  • In the last couple of years the Gross Margin of 1MYCR has remained more or less at the same level.
Industry RankSector Rank
OM 24.93%
PM (TTM) 19.65%
GM 52.94%
OM growth 3Y16.16%
OM growth 5Y0.95%
PM growth 3Y10.73%
PM growth 5Y1.91%
GM growth 3Y5.8%
GM growth 5Y-0.24%
1MYCR.MI Yearly Profit, Operating, Gross Margins1MYCR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

9

2. 1MYCR.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1MYCR is creating value.
  • 1MYCR has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for 1MYCR has been reduced compared to 5 years ago.
  • Compared to 1 year ago, 1MYCR has a worse debt to assets ratio.
1MYCR.MI Yearly Shares Outstanding1MYCR.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
1MYCR.MI Yearly Total Debt VS Total Assets1MYCR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 10.83 indicates that 1MYCR is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 10.83, 1MYCR belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
  • The Debt to FCF ratio of 1MYCR is 0.28, which is an excellent value as it means it would take 1MYCR, only 0.28 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 0.28, 1MYCR belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
  • A Debt/Equity ratio of 0.04 indicates that 1MYCR is not too dependend on debt financing.
  • 1MYCR's Debt to Equity ratio of 0.04 is amongst the best of the industry. 1MYCR outperforms 87.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.28
Altman-Z 10.83
ROIC/WACC2.74
WACC7.12%
1MYCR.MI Yearly LT Debt VS Equity VS FCF1MYCR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • 1MYCR has a Current Ratio of 2.30. This indicates that 1MYCR is financially healthy and has no problem in meeting its short term obligations.
  • 1MYCR's Current ratio of 2.30 is amongst the best of the industry. 1MYCR outperforms 81.48% of its industry peers.
  • A Quick Ratio of 1.54 indicates that 1MYCR should not have too much problems paying its short term obligations.
  • With an excellent Quick ratio value of 1.54, 1MYCR belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.3
Quick Ratio 1.54
1MYCR.MI Yearly Current Assets VS Current Liabilites1MYCR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

6

3. 1MYCR.MI Growth Analysis

3.1 Past

  • 1MYCR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.37%.
  • The Earnings Per Share has been growing by 17.63% on average over the past years. This is quite good.
  • Looking at the last year, 1MYCR shows a quite strong growth in Revenue. The Revenue has grown by 12.48% in the last year.
  • 1MYCR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.38% yearly.
EPS 1Y (TTM)-7.37%
EPS 3Y28.08%
EPS 5Y17.63%
EPS Q2Q%-39.7%
Revenue 1Y (TTM)12.48%
Revenue growth 3Y15.75%
Revenue growth 5Y15.38%
Sales Q2Q%-1.85%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.20% on average over the next years. This is quite good.
  • 1MYCR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.09% yearly.
EPS Next Y6.41%
EPS Next 2Y8.82%
EPS Next 3Y10.2%
EPS Next 5YN/A
Revenue Next Year4.57%
Revenue Next 2Y6.57%
Revenue Next 3Y13.09%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1MYCR.MI Yearly Revenue VS Estimates1MYCR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
1MYCR.MI Yearly EPS VS Estimates1MYCR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

2

4. 1MYCR.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 34.00, 1MYCR can be considered very expensive at the moment.
  • 66.67% of the companies in the same industry are more expensive than 1MYCR, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, 1MYCR is valued a bit more expensive.
  • The Price/Forward Earnings ratio is 32.04, which means the current valuation is very expensive for 1MYCR.
  • 1MYCR's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of 1MYCR to the average of the S&P500 Index (21.99), we can say 1MYCR is valued slightly more expensively.
Industry RankSector Rank
PE 34
Fwd PE 32.04
1MYCR.MI Price Earnings VS Forward Price Earnings1MYCR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1MYCR.
  • Based on the Price/Free Cash Flow ratio, 1MYCR is valued a bit more expensive than 68.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF 42.92
EV/EBITDA 22.23
1MYCR.MI Per share data1MYCR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • 1MYCR has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)5.31
PEG (5Y)1.93
EPS Next 2Y8.82%
EPS Next 3Y10.2%

3

5. 1MYCR.MI Dividend Analysis

5.1 Amount

  • 1MYCR has a Yearly Dividend Yield of 1.20%. Purely for dividend investing, there may be better candidates out there.
  • 1MYCR's Dividend Yield is comparable with the industry average which is at 1.61.
  • Compared to the average S&P500 Dividend Yield of 1.82, 1MYCR is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.2%

5.2 History

  • On average, the dividend of 1MYCR grows each year by 13.40%, which is quite nice.
Dividend Growth(5Y)13.4%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 1MYCR pays out 47.05% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of 1MYCR is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP47.05%
EPS Next 2Y8.82%
EPS Next 3Y10.2%
1MYCR.MI Yearly Income VS Free CF VS Dividend1MYCR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
1MYCR.MI Dividend Payout.1MYCR.MI Dividend Payout, showing the Payout Ratio.1MYCR.MI Dividend Payout.PayoutRetained Earnings

1MYCR.MI Fundamentals: All Metrics, Ratios and Statistics

MYCRONIC AB

BIT:1MYCR (4/16/2026, 7:00:00 PM)

25.16

+5.79 (+29.86%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)04-24
Earnings (Next)07-14
Inst Owners58.42%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap4.93B
Revenue(TTM)7.94B
Net Income(TTM)1.56B
Analysts80
Price Target21.22 (-15.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.2%
Yearly Dividend0.35
Dividend Growth(5Y)13.4%
DP47.05%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.73%
Min EPS beat(2)-12.85%
Max EPS beat(2)3.4%
EPS beat(4)2
Avg EPS beat(4)-1.55%
Min EPS beat(4)-12.85%
Max EPS beat(4)4.37%
EPS beat(8)5
Avg EPS beat(8)8.34%
EPS beat(12)6
Avg EPS beat(12)2.88%
EPS beat(16)7
Avg EPS beat(16)-1.62%
Revenue beat(2)2
Avg Revenue beat(2)4.59%
Min Revenue beat(2)3.48%
Max Revenue beat(2)5.69%
Revenue beat(4)4
Avg Revenue beat(4)4.42%
Min Revenue beat(4)1.52%
Max Revenue beat(4)6.99%
Revenue beat(8)6
Avg Revenue beat(8)4.61%
Revenue beat(12)7
Avg Revenue beat(12)2.51%
Revenue beat(16)8
Avg Revenue beat(16)0.82%
PT rev (1m)1.98%
PT rev (3m)-8.15%
EPS NQ rev (1m)3.62%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.51%
EPS NY rev (3m)-32.19%
Revenue NQ rev (1m)1.46%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)1.77%
Valuation
Industry RankSector Rank
PE 34
Fwd PE 32.04
P/S 6.72
P/FCF 42.92
P/OCF 37.89
P/B 7.5
P/tB 14.88
EV/EBITDA 22.23
EPS(TTM)0.74
EY2.94%
EPS(NY)0.79
Fwd EY3.12%
FCF(TTM)0.59
FCFY2.33%
OCF(TTM)0.66
OCFY2.64%
SpS3.75
BVpS3.35
TBVpS1.69
PEG (NY)5.31
PEG (5Y)1.93
Graham Number7.47304 (-70.3%)
Profitability
Industry RankSector Rank
ROA 14.29%
ROE 21.94%
ROCE 24.37%
ROIC 19.52%
ROICexc 27.33%
ROICexgc 69.67%
OM 24.93%
PM (TTM) 19.65%
GM 52.94%
FCFM 15.65%
ROA(3y)14.14%
ROA(5y)13.2%
ROE(3y)22.24%
ROE(5y)20.71%
ROIC(3y)20.09%
ROIC(5y)18.35%
ROICexc(3y)31.55%
ROICexc(5y)26.71%
ROICexgc(3y)84.13%
ROICexgc(5y)69.54%
ROCE(3y)25.1%
ROCE(5y)22.92%
ROICexgc growth 3Y20.28%
ROICexgc growth 5Y4.58%
ROICexc growth 3Y18.83%
ROICexc growth 5Y-0.93%
OM growth 3Y16.16%
OM growth 5Y0.95%
PM growth 3Y10.73%
PM growth 5Y1.91%
GM growth 3Y5.8%
GM growth 5Y-0.24%
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.28
Debt/EBITDA 0.11
Cap/Depr 50%
Cap/Sales 2.08%
Interest Coverage 123.69
Cash Conversion 60.94%
Profit Quality 79.62%
Current Ratio 2.3
Quick Ratio 1.54
Altman-Z 10.83
F-Score6
WACC7.12%
ROIC/WACC2.74
Cap/Depr(3y)70.73%
Cap/Depr(5y)62.37%
Cap/Sales(3y)2.94%
Cap/Sales(5y)2.7%
Profit Quality(3y)106.24%
Profit Quality(5y)104.67%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.37%
EPS 3Y28.08%
EPS 5Y17.63%
EPS Q2Q%-39.7%
EPS Next Y6.41%
EPS Next 2Y8.82%
EPS Next 3Y10.2%
EPS Next 5YN/A
Revenue 1Y (TTM)12.48%
Revenue growth 3Y15.75%
Revenue growth 5Y15.38%
Sales Q2Q%-1.85%
Revenue Next Year4.57%
Revenue Next 2Y6.57%
Revenue Next 3Y13.09%
Revenue Next 5YN/A
EBIT growth 1Y-2.17%
EBIT growth 3Y34.46%
EBIT growth 5Y16.48%
EBIT Next Year20.3%
EBIT Next 3Y13%
EBIT Next 5YN/A
FCF growth 1Y-24.08%
FCF growth 3Y20.38%
FCF growth 5Y4.62%
OCF growth 1Y-24.92%
OCF growth 3Y18.15%
OCF growth 5Y4.56%

MYCRONIC AB / 1MYCR.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MYCRONIC AB?

ChartMill assigns a fundamental rating of 6 / 10 to 1MYCR.MI.


Can you provide the valuation status for MYCRONIC AB?

ChartMill assigns a valuation rating of 2 / 10 to MYCRONIC AB (1MYCR.MI). This can be considered as Overvalued.


Can you provide the profitability details for MYCRONIC AB?

MYCRONIC AB (1MYCR.MI) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for 1MYCR stock?

The Price/Earnings (PE) ratio for MYCRONIC AB (1MYCR.MI) is 34 and the Price/Book (PB) ratio is 7.5.


Is the dividend of MYCRONIC AB sustainable?

The dividend rating of MYCRONIC AB (1MYCR.MI) is 3 / 10 and the dividend payout ratio is 47.05%.